Lok Bahadur Shrestha
Biographic Data
| ID | 7036413 |
|---|---|
| NAME | Lok Bahadur Shrestha |
| GIVEN NAMES | Lok Bahadur |
| FAMILY NAME | Shrestha |
| SIGNATURE | SHRESTHA L B |
| AFFILIATIONS | UNSW Sydney |
| ORCID | 0000-0002-0054-0715 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework
The Toolkit holds promise for progressing the WHO elimination goals by increasing advocacy efforts for enhanced prison HCV services globally. The co-design of Toolkit resources with potential end-users has increased its potential accessibility, acceptability, and inclusivity for a globally diverse audience
Barriers and advocacy needs for hepatitis C services in prisons
Asymptomatic Sars-CoV-2 Carriers
Asymptomatic cases of SARS-CoV-2 can be unknown carriers magnifying the transmission of COVID-19. This study appraised the frequency of asymptomatic individuals and estimated occurrence by age group and gender by reviewing the existing published data on asymptomatic people with COVID-19. Three electronic databases, PubMed, Embase, and Web of Science (WoS), were used to search the literature following the guidelines of Preferred Reporting Items fo…
No prominent works on this page.
Asymptomatic Sars-CoV-2 Carriers
Asymptomatic cases of SARS-CoV-2 can be unknown carriers magnifying the transmission of COVID-19. This study appraised the frequency of asymptomatic individuals and estimated occurrence by age group and gender by reviewing the existing published data on asymptomatic people with COVID-19. Three electronic databases, PubMed, Embase, and Web of Science (WoS), were used to search the literature following the guidelines of Preferred Reporting Items fo…
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework
The Toolkit holds promise for progressing the WHO elimination goals by increasing advocacy efforts for enhanced prison HCV services globally. The co-design of Toolkit resources with potential end-users has increased its potential accessibility, acceptability, and inclusivity for a globally diverse audience
Barriers and advocacy needs for hepatitis C services in prisons
Hepatitis C virus research (2 works) · HIV, Drug Use, Sexual Risk (2 works) · HIV/AIDS Research and Interventions (2 works) · Political science (2 works) · Public relations (2 works) · Business (1 work) · Consumer Advocacy (1 work) · Focus group (1 work) · Health care (1 work) · Hepatitis C (1 work)